Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,057 | 616 | 98.8% |
| Education | $206.35 | 11 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,706 | 60 | $0 (2024) |
| Lilly USA, LLC | $2,075 | 86 | $0 (2024) |
| Novo Nordisk Inc | $2,069 | 71 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,758 | 135 | $0 (2024) |
| ABBVIE INC. | $1,379 | 44 | $0 (2024) |
| Allergan, Inc. | $1,082 | 37 | $0 (2022) |
| PFIZER INC. | $743.07 | 30 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $648.14 | 19 | $0 (2019) |
| Amarin Pharma Inc. | $596.21 | 18 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $414.21 | 14 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,382 | 88 | AstraZeneca Pharmaceuticals LP ($825.20) |
| 2023 | $1,421 | 71 | AstraZeneca Pharmaceuticals LP ($348.53) |
| 2022 | $2,458 | 85 | Novo Nordisk Inc ($455.73) |
| 2021 | $2,435 | 113 | Novo Nordisk Inc ($389.37) |
| 2020 | $1,321 | 64 | AstraZeneca Pharmaceuticals LP ($307.63) |
| 2019 | $2,177 | 58 | AstraZeneca Pharmaceuticals LP ($463.69) |
| 2018 | $1,822 | 65 | GlaxoSmithKline, LLC. ($282.17) |
| 2017 | $2,246 | 83 | Allergan Inc. ($443.69) |
All Payment Transactions
627 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $163.74 | General |
| Category: WaveWriter Alpha NMD | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $109.82 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $36.37 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.52 | General |
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $118.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $124.93 | General |
| Category: Neurology | ||||||
| 10/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.09 | General |
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.19 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: GI | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Cardio-renal | ||||||
| 08/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $19.44 | General |
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 737 | 1,182 | $220,111 | $97,848 |
| 2022 | 19 | 1,063 | 1,797 | $299,835 | $129,799 |
| 2021 | 15 | 945 | 1,661 | $305,665 | $140,617 |
| 2020 | 13 | 862 | 1,857 | $352,511 | $139,503 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 556 | $122,633 | $49,539 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 102 | 102 | $27,603 | $13,762 | 49.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 113 | 113 | $11,832 | $9,066 | 76.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 120 | $15,551 | $8,111 | 52.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 37 | $11,134 | $5,019 | 45.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 22 | $6,565 | $3,814 | 58.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $10,501 | $2,534 | 24.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 106 | 106 | $2,775 | $2,109 | 76.0% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 17 | 23 | $5,544 | $1,970 | 35.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 14 | $1,759 | $850.77 | 48.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 11 | 17 | $2,040 | $614.40 | 30.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 41 | $2,174 | $458.04 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 217 | 619 | $133,363 | $54,285 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 132 | 132 | $35,439 | $18,082 | 51.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 155 | 163 | $17,068 | $13,122 | 76.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 134 | $16,696 | $7,904 | 47.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 37 | $10,426 | $5,148 | 49.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 41 | 122 | $14,640 | $5,090 | 34.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 29 | 96 | $13,680 | $4,888 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $14,980 | $4,856 | 32.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 22 | 73 | $11,680 | $3,649 | 31.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 141 | 141 | $3,691 | $2,832 | 76.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 15 | $4,378 | $2,617 | 59.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 26 | 26 | $3,267 | $1,613 | 49.4% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 13 | 14 | $2,496 | $1,324 | 53.1% |
About Dr. Stuart Lerner, MD
Dr. Stuart Lerner, MD is a Emergency Medicine healthcare provider based in Kailua, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881647782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Lerner, MD has received a total of $17,263 in payments from pharmaceutical and medical device companies, with $3,382 received in 2024. These payments were reported across 627 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($17,057).
As a Medicare-enrolled provider, Lerner has provided services to 3,607 Medicare beneficiaries, totaling 6,497 services with total Medicare billing of $507,767. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Kailua, HI
- Active Since 05/19/2006
- Last Updated 10/22/2021
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881647782
Products in Payments
- FARXIGA (Drug) $1,736
- VRAYLAR (Drug) $1,234
- Ozempic (Drug) $1,114
- TRELEGY ELLIPTA (Drug) $1,005
- TRULICITY (Drug) $958.51
- JARDIANCE (Drug) $650.25
- BREZTRI (Drug) $625.71
- Vascepa (Drug) $596.21
- MOUNJARO (Drug) $521.55
- BOTOX (Biological) $449.47
- AJOVY (Drug) $308.63
- ANORO (Drug) $285.46
- PROCLAIM (Device) $264.82
- Livalo (Drug) $206.79
- NURTEC ODT (Drug) $198.82
- LINZESS (Drug) $195.68
- Kerendia (Drug) $192.61
- AIRSUPRA (Drug) $186.56
- Xofluza (Drug) $184.80
- EUCRISA (Drug) $179.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Kailua
Vincent Ritson, M.d, M.D
Emergency Medicine — Payments: $4,609
Dr. Jason Woo, M.d, M.D
Emergency Medicine — Payments: $2,400
Scott Sanderson, Md, MD
Emergency Medicine — Payments: $1,708
Rupalkunverba Gohil, M.d, M.D
Emergency Medicine — Payments: $1,029
Dr. Jennifer Lee, M.d, M.D
Emergency Medicine — Payments: $1,023
Dr. Juliana Minak, M.d, M.D
Emergency Medicine — Payments: $534.40